@kali-cohn.bsky.social
Reposted
Happy to share some new #LongCOVID data that went to pre-print today. Before we begin breaking this down, one caveat: this work MUST be validated by a well-powered placebo-controlled randomized controlled trial before we can get too excited, but this is
www.researchsquare.com/article/rs-7...
1/
www.researchsquare.com/article/rs-7...
1/
Comparison of IMC-2 alone and IMC-2 and Paxlovid® shows substantial short and long-term efficacy in reducing symptoms of Long COVID with combination therapy: a case series
IntroductionLong COVID (LC), an infection-associated chronic illness (IACI) with no currently approved treatments. In order to address SARS-CoV-2 persistence and herpesvirus reactivation, which have b...
www.researchsquare.com
September 3, 2025 at 12:50 PM
Happy to share some new #LongCOVID data that went to pre-print today. Before we begin breaking this down, one caveat: this work MUST be validated by a well-powered placebo-controlled randomized controlled trial before we can get too excited, but this is
www.researchsquare.com/article/rs-7...
1/
www.researchsquare.com/article/rs-7...
1/